Cinacalcet
Back to searchMolecule Structure
Scientific Name
Cinacalcet
Description of the Drug
Cinacalcet is a calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01012
http://www.drugbank.ca/drugs/DB01012
Brand Name(s)
Sensipar
Company Owner(s)
Cipla Ltd, The Acme Laboratories Ltd, Alkem Laboratories Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Piramal Healthcare Uk Ltd, Sun Pharmaceutical Industries Ltd, Accord Healthcare Inc, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Hetero Labs Ltd Unit V
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Calcium sensing receptor | SINGLE PROTEIN | POSITIVE ALLOSTERIC MODULATOR | CHEMBL1878 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL71876 | ||
PharmGKB | PA164776671 | ||
Human Metabolome Database | HMDB0015147 | ||
DrugBank | DB01012 | ||
PubChem: Thomson Pharma | 14828105 | ||
PubChem | 156419 | ||
LINCS | LSM-5815 | ||
Nikkaji | J1.645.239D | ||
PDBe | YP4 | ||
BindingDB | 50416875 | ||
EPA CompTox Dashboard | DTXSID8048286 | ||
DrugCentral | 647 | ||
ChemicalBook | CB5506688 | ||
Guide to Pharmacology | 3308 | ||
rxnorm | SENSIPAR | CINACALCET | CINACALCET HYDROCHLORIDE |
ChEBI | 48390 | ||
ZINC | ZINC000001550499 |